Valeant Pharmaceuticals International (NYSE: VRX) said it will restructure its operations to reduce costs and accelerate its earnings growth, and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE